Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Kröner, C; Wittmann, T; Reu, S; Teusch, V; Klemme, M; Rauch, D; Hengst, M; Kappler, M; Cobanoglu, N; Sismanlar, T; Aslan, AT; Campo, I; Proesmans, M; Schaible, T; Terheggen-Lagro, S; Regamey, N; Eber, E; Seidenberg, J; Schwerk, N; Aslanidis, C; Lohse, P; Brasch, F; Zarbock, R; Griese, M.
Lung disease caused by ABCA3 mutations.
Thorax. 2017; 72(3):213-220 Doi: 10.1136/thoraxjnl-2016-208649 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Eber Ernst
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Knowledge about the clinical spectrum of lung disease caused by variations in the ATP binding cassette subfamily A member 3 (ABCA3) gene is limited. Here we describe genotype-phenotype correlations in a European cohort. We retrospectively analysed baseline and outcome characteristics of 40 patients with two disease-causing ABCA3 mutations collected between 2001 and 2015. Of 22 homozygous (15 male) and 18 compound heterozygous patients (3 male), 37 presented with neonatal respiratory distress syndrome as term babies. At follow-up, two major phenotypes are documented: patients with (1) early lethal mutations subdivided into (1a) dying within the first 6 months or (1b) before the age of 5 years, and (2) patients with prolonged survival into childhood, adolescence or adulthood. Patients with null/null mutations predicting complete ABCA3 deficiency died within the 1st weeks to months of life, while those with null/other or other/other mutations had a more variable presentation and outcome. Treatment with exogenous surfactant, systemic steroids, hydroxychloroquine and whole lung lavages had apparent but many times transient effects in individual subjects. Overall long-term (>5 years) survival of subjects with two disease-causing ABCA3 mutations was <20%. Response to therapies needs to be ascertained in randomised controlled trials. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Find related publications in this database (using NLM MeSH Indexing)
ATP-Binding Cassette Transporters - genetics
Adolescent -
Adult -
Biopsy -
Bronchoalveolar Lavage Fluid - chemistry
Child -
Child, Preschool -
Consanguinity -
Diagnostic Imaging -
Female -
Genotype -
Humans -
Immunohistochemistry -
Infant -
Infant, Newborn -
Lung Diseases, Interstitial - genetics
Lung Diseases, Interstitial - mortality
Male -
Microscopy, Electron -
Mutation -
Phenotype -
Retrospective Studies -
Survival Analysis -

© Med Uni GrazImprint